10.3205/11DKVF040
Adarkwah, Charles Christian
Charles Christian
Adarkwah
Gandjour, Afschin
Afschin
Gandjour
Akkerman, Maren
Maren
Akkerman
Evers, Silvia
Silvia
Evers
Cost-effectiveness of angiotensin-converting enzyme inhibitors for the prevention of diabetic nephropathy in the Netherlands – a Markov model
German Medical Science GMS Publishing House
2011
ConferencePaper
610 Medical sciences; Medicine
Deutsches Netzwerk Versorgungsforschung|Gesellschaft Für Arzneimittelanwendungsforschung Und Arzneimittelepidemiologie
2011-10-12
2011
en
urn:nbn:de:0183-11dkvf0404
text/html
10. Deutscher Kongress für Versorgungsforschung; 18. GAA-Jahrestagung
Objective: Type 2 diabetes is the main cause of end-stage renal disease (ESRD) in the Netherlands [ref:1] as well as in other European countries and the United States [ref:2], [ref:3]. Angiotensin-converting enzyme (ACE) inhibitors have a potential to slow down the prog[for full text, please go to the a.m. URL]
10. Deutscher Kongress für Versorgungsforschung; 18. GAA-Jahrestagung